EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 38 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,930,000 | -11.6% | 392,001 | -12.9% | 0.04% | -12.8% |
| Q1 2022 | $4,446,000 | -1.2% | 450,000 | -0.1% | 0.05% | +4.4% |
| Q4 2021 | $4,498,000 | -0.6% | 450,657 | -0.9% | 0.04% | -2.2% |
| Q3 2021 | $4,526,000 | -2.3% | 454,657 | 0.0% | 0.05% | +4.5% |
| Q2 2021 | $4,633,000 | +2.0% | 454,657 | +1.0% | 0.04% | 0.0% |
| Q1 2021 | $4,541,000 | -13.6% | 450,000 | -10.0% | 0.04% | -40.5% |
| Q4 2020 | $5,255,000 | – | 500,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 248,674 | $2,578,749 | 1.28% |
| Verition Fund Management LLC | 397,603 | $4,115,191 | 0.06% |
| CLEAR STREET LLC | 2,740 | $28 | 0.00% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1 | $10 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |